全文获取类型
收费全文 | 156526篇 |
免费 | 32893篇 |
国内免费 | 2426篇 |
学科分类
医药卫生 | 191845篇 |
出版年
2024年 | 514篇 |
2023年 | 4814篇 |
2022年 | 1196篇 |
2021年 | 3258篇 |
2020年 | 6106篇 |
2019年 | 2356篇 |
2018年 | 7569篇 |
2017年 | 7483篇 |
2016年 | 8557篇 |
2015年 | 8597篇 |
2014年 | 15725篇 |
2013年 | 15925篇 |
2012年 | 6024篇 |
2011年 | 6050篇 |
2010年 | 10660篇 |
2009年 | 14543篇 |
2008年 | 6243篇 |
2007年 | 4504篇 |
2006年 | 6938篇 |
2005年 | 4303篇 |
2004年 | 3480篇 |
2003年 | 2440篇 |
2002年 | 2552篇 |
2001年 | 3844篇 |
2000年 | 3049篇 |
1999年 | 3288篇 |
1998年 | 3739篇 |
1997年 | 3520篇 |
1996年 | 3413篇 |
1995年 | 3248篇 |
1994年 | 1992篇 |
1993年 | 1609篇 |
1992年 | 1393篇 |
1991年 | 1426篇 |
1990年 | 1084篇 |
1989年 | 1191篇 |
1988年 | 1029篇 |
1987年 | 867篇 |
1986年 | 898篇 |
1985年 | 735篇 |
1984年 | 562篇 |
1983年 | 528篇 |
1982年 | 519篇 |
1981年 | 410篇 |
1980年 | 366篇 |
1979年 | 322篇 |
1978年 | 336篇 |
1977年 | 402篇 |
1975年 | 285篇 |
1972年 | 289篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
81.
82.
Renaud Snanoudj Nassim Kamar Elisabeth Cassuto Sophie Caillard Marie Metzger Pierre Merville Antoine Thierry Isabelle Jollet Philippe Grimbert Dany Anglicheau Marc Hazzan Gabriel Choukroun Bruno Hurault De Ligny Bénedicte Janbon Vincent Vuiblet Anne Devys Yann Le Meur Michel Delahousse Jean-Luc Taupin 《Kidney international》2019,95(6):1471-1485
83.
Darren R. Feldman MD Yasser Ged MBBS Chung-Han Lee PhD Andrea Knezevic MS Ana M. Molina MD Ying-Bei Chen PhD Joshua Chaim DO Devyn T. Coskey MS Samuel Murray MS Satish K. Tickoo MD Victor E. Reuter MD Sujata Patil PhD Han Xiao MD Jahan Aghalar MD Arlyn J. Apollo MD Maria I. Carlo MD Robert J. Motzer MD Martin H. Voss MD 《Cancer》2020,126(24):5247-5255
84.
James I. Geller MD Joseph G. Pressey MD Malcolm A. Smith MD Rachel A. Kudgus PhD Mariana Cajaiba MD Joel M. Reid PhD David Hall PhD Donald A. Barkauskas PhD Stephen D. Voss MD Steve Y. Cho MD Stacey L. Berg MD Jeffrey S. Dome MD PhD Elizabeth Fox MD Brenda J. Weigel MD 《Cancer》2020,126(24):5303-5310
85.
86.
87.
88.
This work describes the synthesis and tumor affinity testing of 8-[123I]iodo-l-1,2,3,4-tetrahydro-7-hydroxyisoquinoline-3-carboxylic acid [ITIC(OH)], a cyclic non-naturally occurring amino acid as an imaging probe for prostate cancer. Parameters for labelling were optimized with regard to the amount of precursor, the temperature and time. Thereafter, ITIC(OH) was evaluated in terms of its uptake in primary human PC-3 and DU-145 prostate cancer cells, followed by analysis of the underlying mechanisms of the radioactivity accumulation in tumor cells. No-carrier-added ITIC(OH) was obtained in 80+/-15% radiochemical yield and >98% radiochemical purity by a one-step radioiodination, using IODO-GEN as oxidant. The total synthesis time was less than 30 min, and compatible with a clinical routine production. ITIC(OH) accumulated intensively in primary human prostate cancer cells. The radioactivity incorporation in tumor following a 10-min incubation at 37 degrees C/pH 7.4 varied from 35% to 58% of the total loaded activity per 10(6) tumor cells (355-540 cpm/1000 cells). Inhibition experiments revealed that ITIC(OH) was taken up into tumor by an active transport different from the common amino acid carrier systems, including the sodium-dependent system A and B+,0, and the sodium-independent L- and ASC-type transporter. In contrast, the cellular incorporation was dependent on the membrane potential and correlated with the activity of the mitochondria. In conclusion, the specific and high-level accumulation of ITIC(OH) in human prostate carcinoma cells, indicates that the new radiopharmaceutical is a good candidate for further in vivo investigations to ascertain its potential as an imaging probe for prostate cancer by SPET. 相似文献
89.
Juliette A. Loncaster MD FRCR Ernest Allan 《Photodiagnosis and Photodynamic Therapy》2006,3(2):134-137
Gorlin syndrome (naevoid basal cell carcinoma syndrome) is a genetically linked disorder characterized by the development of multiple basal cell carcinomas (BCCs) throughout life. Cumulative surgery, cryotherapy and other conventional interventions can result in significant disfigurement by middle age. Radiotherapy is contra-indicated because the mutated gene underlying the syndrome, ‘PTCH’, increases sensitivity to ionising radiation, so there is significant likelihood of inducing further tumours in and around the irradiated area. Photodynamic therapy offers a non-invasive treatment option for patients with this condition, with the added advantage of causing minimal scarring. 相似文献
90.